Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148771 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion
A Phase 4 study, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT01148771 is a Phase 4 study that has completed, run by Hartford Hospital. The registered enrollment target is 12 participants.
The verdict
NCT01148771, a Phase 4 study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize and compare the concentration-time profiles and multiple dose pharmacokinetics of a 5 minute intravenous (IV) bolus of ertapenem 1 gram daily versus the standard 30 minute infusion in healthy volunteers. Safety and tolerability and pharmacodynamic target attainment using Monte Carlo simulation will also be assessed and compared.
Interventions
- DRUG ertapenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148771
The ClinicalTrials.gov registry entry for NCT01148771 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ertapenem is the first listed.
NCT01148771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01148771 about?
NCT01148771 is a clinical study titled "Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion". The purpose of this study is to characterize and compare the concentration-time profiles and multiple dose pharmacokinetics of a 5 minute intravenous (IV) bolus of ertapenem 1 gram daily versus the standard 30 minute infusion in healthy volunteers. Safety and tolerability and pharmacodynamic target ...
What is the current status of trial NCT01148771?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01148771?
The interventions under investigation include: ertapenem (DRUG).
Who is sponsoring clinical trial NCT01148771?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.